Copyright Reports & Markets. All rights reserved.

Global Human Interleukin-11 for Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Interleukin-11 for Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 1mg
    • 1.3.3 1.5mg
    • 1.3.4 3mg
    • 1.3.5 5mg
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Interleukin-11 for Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
  • 1.5 Global Human Interleukin-11 for Injection Market Size & Forecast
    • 1.5.1 Global Human Interleukin-11 for Injection Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Human Interleukin-11 for Injection Sales Quantity (2020-2031)
    • 1.5.3 Global Human Interleukin-11 for Injection Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Xiamen Amoytop Biotech
    • 2.1.1 Xiamen Amoytop Biotech Details
    • 2.1.2 Xiamen Amoytop Biotech Major Business
    • 2.1.3 Xiamen Amoytop Biotech Human Interleukin-11 for Injection Product and Services
    • 2.1.4 Xiamen Amoytop Biotech Human Interleukin-11 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Xiamen Amoytop Biotech Recent Developments/Updates
  • 2.2 SL Pharm
    • 2.2.1 SL Pharm Details
    • 2.2.2 SL Pharm Major Business
    • 2.2.3 SL Pharm Human Interleukin-11 for Injection Product and Services
    • 2.2.4 SL Pharm Human Interleukin-11 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 SL Pharm Recent Developments/Updates
  • 2.3 Qilu Pharmaceutical
    • 2.3.1 Qilu Pharmaceutical Details
    • 2.3.2 Qilu Pharmaceutical Major Business
    • 2.3.3 Qilu Pharmaceutical Human Interleukin-11 for Injection Product and Services
    • 2.3.4 Qilu Pharmaceutical Human Interleukin-11 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.4 Angde Biotech Pharmaceutical
    • 2.4.1 Angde Biotech Pharmaceutical Details
    • 2.4.2 Angde Biotech Pharmaceutical Major Business
    • 2.4.3 Angde Biotech Pharmaceutical Human Interleukin-11 for Injection Product and Services
    • 2.4.4 Angde Biotech Pharmaceutical Human Interleukin-11 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Angde Biotech Pharmaceutical Recent Developments/Updates
  • 2.5 Hangzhou Jiuyuan Gene Engineering
    • 2.5.1 Hangzhou Jiuyuan Gene Engineering Details
    • 2.5.2 Hangzhou Jiuyuan Gene Engineering Major Business
    • 2.5.3 Hangzhou Jiuyuan Gene Engineering Human Interleukin-11 for Injection Product and Services
    • 2.5.4 Hangzhou Jiuyuan Gene Engineering Human Interleukin-11 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates

3 Competitive Environment: Human Interleukin-11 for Injection by Manufacturer

  • 3.1 Global Human Interleukin-11 for Injection Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Human Interleukin-11 for Injection Revenue by Manufacturer (2020-2025)
  • 3.3 Global Human Interleukin-11 for Injection Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Human Interleukin-11 for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Human Interleukin-11 for Injection Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Human Interleukin-11 for Injection Manufacturer Market Share in 2024
  • 3.5 Human Interleukin-11 for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Human Interleukin-11 for Injection Market: Region Footprint
    • 3.5.2 Human Interleukin-11 for Injection Market: Company Product Type Footprint
    • 3.5.3 Human Interleukin-11 for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Interleukin-11 for Injection Market Size by Region
    • 4.1.1 Global Human Interleukin-11 for Injection Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Human Interleukin-11 for Injection Consumption Value by Region (2020-2031)
    • 4.1.3 Global Human Interleukin-11 for Injection Average Price by Region (2020-2031)
  • 4.2 North America Human Interleukin-11 for Injection Consumption Value (2020-2031)
  • 4.3 Europe Human Interleukin-11 for Injection Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Human Interleukin-11 for Injection Consumption Value (2020-2031)
  • 4.5 South America Human Interleukin-11 for Injection Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Human Interleukin-11 for Injection Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Human Interleukin-11 for Injection Sales Quantity by Type (2020-2031)
  • 5.2 Global Human Interleukin-11 for Injection Consumption Value by Type (2020-2031)
  • 5.3 Global Human Interleukin-11 for Injection Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Human Interleukin-11 for Injection Sales Quantity by Application (2020-2031)
  • 6.2 Global Human Interleukin-11 for Injection Consumption Value by Application (2020-2031)
  • 6.3 Global Human Interleukin-11 for Injection Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Human Interleukin-11 for Injection Sales Quantity by Type (2020-2031)
  • 7.2 North America Human Interleukin-11 for Injection Sales Quantity by Application (2020-2031)
  • 7.3 North America Human Interleukin-11 for Injection Market Size by Country
    • 7.3.1 North America Human Interleukin-11 for Injection Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Human Interleukin-11 for Injection Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Human Interleukin-11 for Injection Sales Quantity by Type (2020-2031)
  • 8.2 Europe Human Interleukin-11 for Injection Sales Quantity by Application (2020-2031)
  • 8.3 Europe Human Interleukin-11 for Injection Market Size by Country
    • 8.3.1 Europe Human Interleukin-11 for Injection Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Human Interleukin-11 for Injection Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Interleukin-11 for Injection Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Human Interleukin-11 for Injection Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Human Interleukin-11 for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Human Interleukin-11 for Injection Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Human Interleukin-11 for Injection Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Human Interleukin-11 for Injection Sales Quantity by Type (2020-2031)
  • 10.2 South America Human Interleukin-11 for Injection Sales Quantity by Application (2020-2031)
  • 10.3 South America Human Interleukin-11 for Injection Market Size by Country
    • 10.3.1 South America Human Interleukin-11 for Injection Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Human Interleukin-11 for Injection Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Interleukin-11 for Injection Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Human Interleukin-11 for Injection Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Human Interleukin-11 for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Human Interleukin-11 for Injection Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Human Interleukin-11 for Injection Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Human Interleukin-11 for Injection Market Drivers
  • 12.2 Human Interleukin-11 for Injection Market Restraints
  • 12.3 Human Interleukin-11 for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Interleukin-11 for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Interleukin-11 for Injection
  • 13.3 Human Interleukin-11 for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Interleukin-11 for Injection Typical Distributors
  • 14.3 Human Interleukin-11 for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Interleukin-11 for Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Recombinant Human Interleukin-11 for Injection is a drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Recombinant human interleukin-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, oprelvekin, and rhIL-11.
    Human Interleukin-11 for Injection is a biopharmaceutical with a wide range of potential applications. The market demand is steadily increasing, particularly in areas such as cancer treatment and bone marrow suppression, leading to rising sales. Its specific uses include promoting platelet production, alleviating leukopenia symptoms, and improving the outcomes of stem cell transplantation. The future development prospects are promising, as research and applications of Human Interleukin-11 continue to expand in the rapidly evolving field of biopharmaceuticals, offering effective options for the treatment of various diseases.
    This report is a detailed and comprehensive analysis for global Human Interleukin-11 for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Interleukin-11 for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Human Interleukin-11 for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Human Interleukin-11 for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Human Interleukin-11 for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Interleukin-11 for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Interleukin-11 for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xiamen Amoytop Biotech, SL Pharm, Qilu Pharmaceutical, Angde Biotech Pharmaceutical, Hangzhou Jiuyuan Gene Engineering, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Interleukin-11 for Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    1mg
    1.5mg
    3mg
    5mg
    Other
    Market segment by Application
    Hospital
    Pharmacy
    Major players covered
    Xiamen Amoytop Biotech
    SL Pharm
    Qilu Pharmaceutical
    Angde Biotech Pharmaceutical
    Hangzhou Jiuyuan Gene Engineering
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Interleukin-11 for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Interleukin-11 for Injection, with price, sales quantity, revenue, and global market share of Human Interleukin-11 for Injection from 2020 to 2025.
    Chapter 3, the Human Interleukin-11 for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Interleukin-11 for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Interleukin-11 for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Interleukin-11 for Injection.
    Chapter 14 and 15, to describe Human Interleukin-11 for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now